Who is sponsoring NCT01206699?

NCT01206699 is sponsored by Nantes University Hospital.

What condition does NCT01206699 study?

NCT01206699 studies Subjects Suffering of Lateralized Lumbago on Side of the Malformation (Neo-articulation).

What drugs are being tested in NCT01206699?

Interventions: corticoid (altim® 1.5 ml), physiological solution (1.5 ml).

What is the status of NCT01206699?

NCT01206699 is currently TERMINATED.

Last reviewed 2015-11-02 · How we verify

Involvement of Transverso-sacral- Neo- Articulations or of Transverso-iliac Articulations in Chronic Lumbago: Prospective Multicentric , Double-Blinded, Randomized of the Efficacy of corticoïd Infiltration Versus Physiological Solution Infiltration

NCT01206699 Phase 4 TERMINATED

The specific aim of this study is to determine whether, when treated with corticoid infiltration, certain chronic lumbagos could be explained by the presence of a neo-articulation.The primary criteria is to determine the difference between the mean pain during the latest 24 hours preceding the infiltration and the mean pain preceding the visit S4 (visit 4 weeks after the infiltration)

Details

Lead sponsor	Nantes University Hospital
Phase	Phase 4
Status	TERMINATED
Enrolment	16
Start date	2010-09
Completion	2015-02

Conditions

Subjects Suffering of Lateralized Lumbago on Side of the Malformation (Neo-articulation)

Interventions

corticoid (altim® 1.5 ml)
physiological solution (1.5 ml)

Primary outcomes

To determine the difference between the mean pain during the latest 24 hours preceding the infiltration and the mean pain preceding the visit S4 (visit 4 weeks after the infiltration) — week 4
To determine whether, when treated with corticoid infiltration, certain chronic lumbagos could be explained by the presence of a neo-articulation.The primary criteria is to determine the difference between the mean pain during the latest 24 hours preceding the infiltration and the mean pain preceding the visit S4 (visit 4 weeks after the infiltration)

Countries

France